[Federal Register Volume 68, Number 18 (Tuesday, January 28, 2003)]
[Notices]
[Page 4233]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-1914]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 21, 2002, Bristol-Myers 
Squibb Pharma Company, 1000 Stewart Avenue, Garden City, New York 
11530, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                            Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)............................................          II
Hydrocodone (9193)..........................................          II
Oxymorphone (9652)..........................................          II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
make finished products.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representatives 
(CCR), and must be filed no later than (60 days from publication).

    Dated: January 6, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-1914 Filed 1-27-03; 8:45 am]
BILLING CODE 4410-09-M